Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
4821 studies found for:    "Diabetes Mellitus, Type 2"
Show Display Options
RSS Create an RSS feed from your search for:
"Diabetes Mellitus, Type 2"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Partners for Better Health in Adolescent Type 2 Diabetes: The Buddy Study
Conditions: Obesity;   Diabetes Mellitus, Type 2;   Abnormal Glucose Metabolism;   Type 2 Diabetes
Intervention: Behavioral: Assignment of a Lay Patient Partner
2 Completed Clinical Assessment of GSK716155 for Type 2 Diabetes Mellitus
Conditions: Type 2 Diabetes Mellitus;   Diabetes Mellitus, Type 2
Intervention: Drug: GSK716155 for injection
3 Completed A Study Of Rosiglitazone Plus Insulin To Treat Type 2 Diabetes Mellitus Patients
Conditions: Type 2 Diabetes Mellitus;   Diabetes Mellitus, Type 2
Intervention: Drug: Rosiglitazone 4 mg
4 Completed Drug Interactions From Simultaneous Administration Of Metformin And GSK189075 To Subjects With Type 2 Diabetes
Conditions: Type 2 Diabetes Mellitus;   Diabetes Mellitus, Type 2
Interventions: Drug: GSK189075 oral tablets;   Drug: metformin tablets
5 Completed Study Of AVANDAMET With Or Without Insulin In Type II Diabetes Mellitus Patients
Conditions: Diabetes Mellitus, Type 2;   Non-Insulin-Dependent Diabetes Mellitus
Intervention: Drug: Rosiglitazone/metformin
6 Completed An Evaluation of Glycemic Control Effects of Mono Therapy CKD-501 in Patients With Type 2 Diabetes Mellitus
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: CKD-501 0.5mg;   Drug: Placebo
7 Completed A Study of the Safety, Pharmacokinetics, and Pharmacodynamics of CNTO 3649 in Healthy Adults and Patients With Type 2 Diabetes Mellitus
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: CNTO 3649 IV (Healthy participants);   Drug: CNTO 3649 SC (Healthy participants);   Drug: CNTO 3649 SC (Diabetic patients);   Drug: Placebo
8 Withdrawn A Study in Patients With Type 2 Diabetes
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: LY2608204;   Drug: Glimepiride
9 Active, not recruiting Evaluation of Blood Pressure Reduction, Safety, and Tolerability of Canagliflozin in Patients With Hypertension and Type 2 Diabetes Mellitus on Stable Doses of Anti-hyperglycemic and Anti-hypertensive Agents
Conditions: Diabetes Mellitus, Type 2;   Hypertension
Interventions: Drug: Canagliflozin;   Drug: Placebo
10 Completed Plant-Based Dietary Intervention in Type 2 Diabetes
Condition: Diabetes Mellitus, Type 2
Intervention: Behavioral: Low-fat, low-Glycemic Index, vegan diet
11 Suspended Plant-Based Dietary Intervention in Type 2 Diabetes-2
Condition: Diabetes Mellitus, Type 2
Intervention: Behavioral: Low-fat, low-Glycemic Index, vegan diet
12 Active, not recruiting Immune Profile and Complication Risk in Type 2 Diabetes
Condition: Diabetes Mellitus, Type 2
Intervention:
13 Recruiting Arterial Stiffness and Complication Risk in Type 2 Diabetes
Conditions: Diabetes Mellitus, Type 2;   Diabetes Complications;   Diabetic Angiopathies;   Diabetic Nephropathies
Intervention:
14 Completed Observational Study in Japanese Type 2 Diabetes Patients
Condition: Diabetes Mellitus, Type 2
Intervention: Drug: Insulins
15 Terminated Mitochondrial Dysfunction in Type 2 Diabetes Mellitus and Capacity for Fat Oxidation During Exercise
Conditions: Diabetes Mellitus, Type 2;   Overweight
Intervention: Behavioral: Aerobic exercise program - 8 weeks
16 Completed A Study for Patients With Type 2 Diabetes Mellitus
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: LY2409021;   Drug: Placebo
17 Completed Exercise Training in Patients With Coronary Heart Disease and Type 2 Diabetes
Conditions: Coronary Artery Disease;   Diabetes Mellitus, Type 2;   Atherosclerosis
Intervention: Behavioral: Exercise
18 Completed Characterization of the Incretinpathy in Type 2 Diabetes Initiated After Sixty Years Old
Conditions: Diabetes Mellitus, Type 2;   Insulin Resistance
Intervention:
19 Completed Contraction (Exercise) Mediated Glucose Uptake as a Therapeutic Target in Type 2 Diabetes
Condition: Diabetes Mellitus, Type 2
Intervention: Drug: nitroprusside, pentalong, imdur, AICAR, isoptin
20 Active, not recruiting Effects of Quercetin on Blood Sugar and Blood Vessel Function in Type 2 Diabetes.
Condition: Diabetes Mellitus, Type 2
Interventions: Dietary Supplement: Quercetin;   Drug: Acarbose;   Drug: placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years